ストックスクリーナーアプリを入手
17.50
25.34%
3.538
前日終値:
$13.96
開ける：
$13.88
24時間の取引高:
45,615
Relative Volume:
5.21
時価総額：
$38.43M
収益：
$8.50M
当期純損益:
$-10.94M
株価収益率:
-2.3115
EPS:
-7.57
ネットキャッシュフロー:
$-28.76M
1週間 パフォーマンス:
+27.72%
1か月 パフォーマンス:
+16.65%
6か月 パフォーマンス:
+15.73%
1年 パフォーマンス:
+188.75%
1日の値動き範囲:
$13.88
$18.93
1週間の範囲:
$12.88
$18.93
52週間の値動き範囲:
$3.659
$42.12
Apollomics Inc Stock (APLM) Company Profile
Compare APLM vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
APLM
Apollomics Inc
|
17.50 | 38.43M | 8.50M | -10.94M | -28.76M | -7.57 |
VRTX
Vertex Pharmaceuticals Inc
|
451.63 | 114.63B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
609.94 | 63.95B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.72 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
278.09 | 37.13B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
162.99 | 34.65B | 742.00K | -1.37B | -1.07B | -7.0731 |
Apollomics Inc (APLM) 最新ニュース
Apollomics Inc (APLMW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Apollomics Inc (APLMW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLMW) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics Inc (APLM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
12 Health Care Stocks Moving In Thursday's Intraday Session - Benzinga
Apollomics Inc (APLM) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Apollomics Inc (APLM) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Apollomics (APLM) CFO RSU vesting triggers 3,588-share tax withholding - Stock Titan
Apollomics Inc (APLM) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Apollomics Inc (APLM) Valuation: PE, PB & Fair Value Analysis - TradingKey
Apollomics Inc (APLM) Institutional Confidence - TradingKey
Apollomics Inc (APLM) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Apollomics (APLM) CEO Hung-Wen Chen gains 5,000 shares as RSUs vest - Stock Titan
Apollomics (APLM) director acquires 500 shares through RSU vesting - Stock Titan
Apollomics (APLM) director vests 500 RSUs into Class A shares - Stock Titan
Apollomics (APLM) director receives 500 shares from RSU vesting - Stock Titan
[Form 4] Apollomics Inc. Insider Trading Activity - Stock Titan
Director at Apollomics (APLM) gains 500 shares from vested RSUs - Stock Titan
Apollomics Inc (APLMW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Apollomics Inc (APLMW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Apollomics Inc. (APLM) Faces Pressure Amid Recent Decline – Key Levels to WatchBearish Pattern Stocks - newsline.com
Behavioral Patterns of APLM and Institutional Flows - Stock Traders Daily
[EFFECT] Apollomics Inc. SEC Filing - Stock Titan
APLM SEC FilingsAPOLLOMICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
Apollomics Inc. (APLM) Edges Higher as Stock Tests Resistance Near $14.86Volume Profile - The Legal Advocate
(APLM) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
Apollomics Inc. Warrant (APLMW) Trades Flat at $0.01 Amid Minimal ActivityLow Volatility Picks - newsline.com
Apollomics Inc. Warrant (APLMW) Stalls at $0.01: Micro-Cap Warrant Holds Steady Amid Minimal Trading ActivitySmart Beta Flow - The Legal Advocate
Apollomics Inc. Warrant (APLMW) Holds Steady Near Minimal Levels – A Closer Look at the Biotech DerivativeCup and Handle - The Legal Advocate
Apollomics Warrants (APLMW) Hold at $0.01 After Modest Gain – Tight Trading Range PersistsCommunity Buy Alerts - Newser
APLMW Technical Analysis | Trend, Signals & Chart Patterns | APOLLOMICS INC-27 (NASDAQ:APLMW) - ChartMill
Apollomics Inc. (APLMW) Warrants Trade at $0.01 After Double-Digit DeclineSell Signal Alerts - Newser
Apollomics (APLM) director converts 500 RSUs into Class A shares - Stock Titan
How (APLM) Movements Inform Risk Allocation Models - Stock Traders Daily
Apollomics Inc. (APLM) files F-3/A to register 279,775 Class A shares - Stock Titan
Is Apollomics (APLM) Still a Buy After +10.29% Rally? 2026-05-15Investment Picks - newser.com
Apollomics (APLM) Climbs +0.54% — Resistance at $14.28 in Focus 2026-05-14Social Buy Zones - newser.com
TradingKey - TradingKey
What to expect when Apollomics (APLMW) reports earnings |Hold Rating - Newser
Trading Systems Reacting to (APLM) Volatility - Stock Traders Daily
The labor dynamics in Apollomics (APLM) results |Inventory Turnover - newser.com
APLMW | Apollomics Inc. Warrant Insider Trading - Quiver Quantitative
Is Apollomics (APLMW) dividend sustainable? (Smart Money Exits) 2026-04-29Expert Verified Trades - newser.com
Apollomics (Nasdaq: APLM) slashes 2025 loss amid cost cuts and new vebreltinib deal revenue - Stock Titan
Apollomics Reports Full Year 2025 Financial Results and Provides Clinical Updates and Business Progress - marketscreener.com
How Apollomics Inc. (APLM) Affects Rotational Strategy Timing - Stock Traders Daily
APLM Apollomics highlights oncology pipeline progress and upcoming clinical trial milestones in its latest quarterly earnings report.Gamma Squeeze - Newser
APLM: Strategic restructuring and licensing revenue reduced losses, but liquidity and going concern risks persist - TradingView
Apollomics (NASDAQ: APLM) warns on going concern, defers vebreltinib NDA and writes down asset - Stock Titan
Apollomics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 - marketscreener.com
Apollomics, Inc. Auditor Raises 'Going Concern' Doubt - marketscreener.com
Apollomics Inc (APLM) 財務データ
収益
当期純利益
現金流量
EPS
0.74%
1.44%
大文字化:
|
ボリューム (24 時間):